Furthermore, we stimulated HepG2.2.15 cells by dsRNA to determine the relative contributions of TLR3 to HBV replication and the possible antiviral mechanism of activating TLR3 in HBV-associated HCC. Here, TLR3 is linked to hepatocellular carcinoma.